Wpg Advisers, LLC Exelixis, Inc. Transaction History
Wpg Advisers, LLC
- $107 Billion
- Q1 2025
A detailed history of Wpg Advisers, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Wpg Advisers, LLC holds 2,066 shares of EXEL stock, worth $82,309. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,066
Previous 2,525
18.18%
Holding current value
$82,309
Previous $84.1 Million
9.28%
% of portfolio
0.07%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
606Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.33 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$898 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$591 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$470 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...